Bausch Health Companies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	157	-46	-592	-225	-948
Depreciation & Amortization	1,208	1,267	1,264	1,394	1,552
Other Amortization	94	55	65	99	55
Loss (Gain) From Sale of Assets	-6	-10	-3	-5	86
Asset Writedown & Restructuring Costs	153	29	547	839	615
Stock-Based Compensation	216	150	132	126	128
Provision & Write-off of Bad Debts	71	62	56	51	60
Other Operating Activities	-274	83	145	-2,611	6
Change in Accounts Receivable	-134	-216	-195	-57	-229
Change in Inventory	-12	-267	-322	-198	-16
Change in Accounts Payable	-76	357	158	-75	121
Change in Other Net Operating Assets	3	133	-223	-66	-4
Operating Cash Flow	1,400	1,597	1,032	-728	1,426
Operating Cash Flow Growth	-12.34%	54.75%	-	-	28.35%
Capital Expenditures	-397	-337	-215	-218	-269
Sale of Property, Plant & Equipment	7	7	5	5	669
Cash Acquisitions	-204	-136	-1,890	-45	-
Sale (Purchase) of Intangibles	-10	-3	-57	-50	-14
Investment in Securities	-3	2	-1	5	-4
Other Investing Activities	12	13	13	-	27
Investing Cash Flow	-595	-454	-2,145	-303	409
Long-Term Debt Issued	10,554	661	3,291	6,836	2,100
Total Debt Issued	10,554	661	3,291	6,836	2,100
Long-Term Debt Repaid	-11,191	-1,460	-1,710	-7,846	-3,440
Total Debt Repaid	-11,191	-1,460	-1,710	-7,846	-3,440
Net Debt Issued (Repaid)	-637	-799	1,581	-1,010	-1,340
Repurchase of Common Stock	-24	-26	-24	-31	-52
Other Financing Activities	-81	-43	-82	567	-121
Financing Cash Flow	-742	-868	1,475	-474	-1,513
Foreign Exchange Rate Adjustments	61	-36	9	-23	-19
Net Cash Flow	124	239	371	-1,528	303
Free Cash Flow	1,003	1,260	817	-946	1,157
Free Cash Flow Growth	-20.40%	54.22%	-	-	43.02%
Free Cash Flow Margin	9.77%	13.09%	9.33%	-11.64%	13.72%
Free Cash Flow Per Share	2.67	3.42	2.24	-2.61	3.22
Cash Interest Paid	1,810	1,674	1,533	1,540	1,419
Cash Income Tax Paid	163	61	237	266	240
Levered Free Cash Flow	1,087	1,721	738.13	1,017	1,627
Unlevered Free Cash Flow	1,995	2,533	1,503	1,833	2,464
Change in Working Capital	-219	7	-582	-396	-128

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q